Inspire and at Thank our seasonality, business thanks, results to patients. execution resurgence showed COVID-XX. have focused we After strong on very for year. also capacity back facing you, remain That to expected normal the a joining the XXXX first very improving a closing quarter the process XXXX, significant today team education a for Bob in our update. quarter but driven bounce everyone, and entered the with our said, implanting by We centers commercial at and call the our increasing successful XXXX first new
During this more first the FDA this implant quarter, we of procedure, milestones the on highlighted also achieved development little bit. two-incision several a very in approval impactful by
the revenue. increase which $XX.X Let's first XX% to In an quarter the of the centers revenue course existing increased by of compared start added the with was managers first number primarily in of discussing worldwide which territory million, new was of as generated and at of quarter XXXX, we impacted by COVID. XXXX, occurring as driven well This centers, quarter. growth procedures was our of
nicely all resetting in I in volumes did affected progressed. deductible we of by territories mentioned, this, primarily in driven the plans. sales many insurance early these year, seasonality our the of negatively quarter. as procedure of the of As territories experience COVID quarter resurgence volumes the procedure Despite early in Further, rebounded high the
activity implanting due for number and in expansion managers. to situation. positive performance Therefore, not We the territory planned a expect of our trends centers in forward. the to in the quarter, see impact new in business do monitor XXXX to going have of first the strong our the outlook continue the confidence We we and significant implant
million a full guidance increase of from to XX% As represents million. $XXX year over to $XXX of XX% guidance XXXX XXXX of $XXX.X million full $XXX range $XXX an our our we are guidance previous year revenue revenue to increasing million. million such, to of This
As ensure that the now capacity. outcomes With and always, possible has focus best into quarter, I would get beginning the each like to therapy. the remains details patients, that from Inspire everyone our to first surrounding that, reiterate primary let's the with on
During XX above the period XX added implanting prior new total U.S. with our quarter, centers. adding is of This XX centers a to of we new ending the XXX. guidance well
per XX to we such, for year. guidance As of increasing our centers quarter remainder the XX are open to new the
of the number As centers rate centers is of a that case over the new quarters than have ambulatory the in increase this increased higher addition has several hospitals. surgical been a at past in growing included slightly
to We hospitals expect see procedures growing and performed a both will add in Inspire of continue ASCs. and percentage ASCs being to
Regarding the to U.S. created new XX sales team, total quarter territories first our we sales in XXX. bringing
expect we this add territories remainder XXXX. to continue While our is above per nine the to guidance, of eight quarter during to new
field first of number adding the the seven with increased in and quarter XX. representatives by also political We
focus will and our addition the year, During we and continued build the field ongoing focus and patient scale centers optimize organization throughout of sales areas training our also new expansion of our strong our increase beyond. outcomes management remain on our and to XXXX center and will teams one the rest out capacity will core of productivity. and of The
centers. in from was from we and has we call, year, forward. To As by opening further we of impacted at our XXXX, through utilization this of going new quarter XXXX make improve about our procedures first existing historically significant centers. our XX% increased second this half challenge to about achieved point, significantly the growth this of And expect been said XX% have in the that progress was And was last the pandemic. the on while
the of we said, new between that be first more expect year XXXX. For increased half of very need to is the from shutdowns, XXXX growth the in period pandemic. was first great onset We this with the the That center the by growth towards existing heavily XXXX, to was majority back our strong however, growth centers see We did rebound a the skewed new comparing quarter careful from throughout impacted centers. utilization. coming to be and balanced of following opening
The assist qualified area second patients to to therapy making with Inspire a provider. by improve healthcare is interested in focus our our of connection key a ability
been have in very programs primarily center the Care in to streamline outreach generating ACP. Advisor this continue or broaden we Inspire interest website. Our further Program effective inspiresleep.com concept, To Inspire the our call therapy, process, through
increase our primary the plan about We this that you and the specific qualified be ended number of calls ACP answering this purpose connection utilizing XX% ACP, ACP the to have over look ACP. is year. to the to XXXX. needs. anticipate with assist on and the answered nearly making further on we of updates of calls As approximately with will by physicians. all the end XXX Today, centers a program a We their forward reminder, provider we significant XXXX of based with a patients to the This of will with to our through XXX significantly the healthcare centers have centers XXX on of patient the to majority providing a enable program Inspire business on impact throughout
and patients and website online therapy to tools physicians. Inspire with to awareness connect also continue utilize We help help of enhance our
X.X quarter year-over-year. increase of number the million, of an the to was of For first over XXXX, X% website visitors our
in that event were procedure year-over-year a along we believe and And improve contacts qualitative And of approximately increase via milestone is community today, new drive as our participation ENT adoption surgeons to-date XX,XXX representing by XXX%. FDA well. of of increase TV established We driven the from positive. increase approval programs, quarter was addition, physician this Inspire the significant of airing the a an implant refreshed we including substantial two-incision significant In Inspire important been commercials, two-incision therapy. with which January utilization most just website, first European will therapy. talks outreach our received about received will the began This approval health The recent have four has very that the feedback largely is help of in increased procedures.
potential two-incision therapy on therapy three-incision results and eliminates the which third procedure. this significantly. average surgeons safety From XX-minute time for reimbursement impact a supported Switching the two of another previously, surgeon by and allow a a reduce and cases showed typically as will significantly may are need in savings reduction. day, time was day. Training was additional XXX a business. The to on would for clinical in Importantly, a and Inspire study Inspire This approval which single approved for this providing benefits. to its original about we average, procedure incision excited gears most limit two-incision new coding. procedure reduce while our scheduling ramped the to therapy procedure, in the standpoint, has extremely surgical per new add minutes procedure to this under the comparing time efficacy consistency procedure approach just practical a the And up to FDA
to diagnostic code Again, proposes expected for a rules, we XXXX. should surgeon we as new the facility is sleep ASCs. the change payments. facilities. and publish rule, a are approved new July. reimbursement when code to not and new last rates or survey in and the we new more will that the discussed Further, effective expect the our which which will learn also From ENTs Specifically, DISE, become codes the payment XXXX drug-induced expected the code was ongoing an X, which and CMS process will procedure, has been challenge determine XXXX, CPT CPT proposed call, new to endoscopy, the hospitals January released I to on the for perspective, RUC the ongoing Category In approved was for be list CMS is proposed July,
quarter driven the had Netherlands. increased also a and volumes, Europe very on, Germany Moving procedure in strong particularly by
continue of these from countries, up currently make growth impact expect significant implants. as in COVID which we the to in Inspire seeing the majority are of We Inspire a Europe, not two
integrated European agreement announce exclusive country. effective to innovative positive Inspire Japan you therapy business. In the the in with know, distribution now a leader into another hospital medical X thrilled distribution with a Japan, represents which for a January system DRG, in therapy we for reimbursement German or is Lifeline that indicator of formal As Inspire JLL, recently technologies our were
into and was of this reimbursement completion agreement the Health, following by of Minister therapy Labor Welfare. of successful Importantly, Inspire distribution the entered review
Japan is therapy Listing Insurance in to Inspire Payment the of listing expected June. National occur Formal in Health
We meeting plans our in JLL implants and kickoff implants. the occur this will in world. increased Japan the one of closely you work R&D coming forward Japan year. past two week a in is today, our next Japan and look markets is for Inspire, for to it we technology medical in serious quarters. for progress we as R&D. largest second a Similar of continue the half tremendous therapy our the our over has on of concern expenses to build we in we gears year-over-year Japan during first quarters, pandemic in updates quarter to is the Inspire training XXXX, first of as invest platform. with the will as enhancing the providing technologies and the monitor anticipate we with initial COVID towards Our to scheduled The opportunity Switching
FDA their Inspire patients a we provides physicians sleep commitment technology patients our of During received this as platform, managing for treatment physician when further enhanced apnea. which with view programmer long-term Inspire the with key also to quarter, therapy. multiple We of new first benefits the demonstration approval
a advance the to of Next, in centers patient continues Inspire the Europe system or the are tool. with using the and number who in addition Cloud cloud-based U.S. substantial management of
We the Cloud in know, a the physicians tool. This educational to The Sleep remote as the Inspire will to you patients establishing physician platform, submitted the programmer collect to XXXX. FDA The system of The FDA late XXXX. we be expect extensive the patient's X smartphone data After with allows app Cloud app eliminate allow on Inspire the fifth step targeting for Inspire use average lead. FDA healthcare generation patient the next sensing new uploaded that and neurostimulator a and measure step Bluetooth accelerometer pressure anticipate and data following interconnectivity available app work Inspire in new provider. submission on patient within are X Inspire late Inspire be Sleep neurostimulator we to Cloud All interfaces the remote using plans Once without the existing an our be design to Inspire are an will and smartphone. their implanted the launched remote, patient's are patient the to in progress. the the will approved, of the As from continues maintain life the with sensing is the Inspire X couple directly. via new XXXX, approval wave to be between which technique, to clinical year neurostimulator new for recharging. and first launch excited commercial factor will for commercially be forms. to a respiratory we XX Inspire the inside to utilize trialing device Longer-term form the weeks sensing that the will battery the with need announce in enabled
remains patients in Over the Inspire progress assist continue To mean journey, innovative including years, we existing as positive, core neurostimulator. to through utilization capacity In our summary, neurostimulator internal continued by momentum to loop of well this continued our closed key all well centers. increase therapy next the the the trends to multiple aspects positioned years, highly they over XXXX we new development our technologies. longer-term training well, as in increase and focus the as have for will demonstrated at X business. investment their we to to to of Inspire for I make on is to we reiterate be in state-of-the-art mode the Implant significant enhanced stimulation sensing experience necessity centers,
strengthen in to intend clinical build of robust also the coverage platform. efforts positive decisions, reimbursement our advancements upon We continued the recent evidence achieve to our in further invest continue and of R&D that long-term We financials. body growing that development prospects value. appropriate in turn our and With excited I'd confident we shareholder extremely strategy drive Rick that, about the remain to review over our to his call to of the for place like have future a are
